Women Are Struggling With Sex, Pooping, and Even Sitting. You Can Guess How Insurers Are Reacting.

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily.
Clinical Trials Arena on MSN

EG 427’s HSV gene therapy reduces urinary incontinence in Phase Ib/IIa trial

French biotech EG 427 has had success with its urinary incontinence DNA therapy, EG110A, showing a more than 80% reduction in ...